Interleukin-30 Subverts Prostate Cancer-Endothelium Crosstalk by Fostering Angiogenesis and Activating Immunoregulatory and Oncogenic Signaling Pathways

Prostate cancer-endothelial cell interactions were investigated, after coculture, by flow cytometry, transcriptional profiling, western blot, and ELISA assays.